Home Magazines Editors-in-Chief FAQs Contact Us

Treatment of sexual dysfunction, with platelet rich plasma in woman cancer survivors

Obstetrics & Gynecology International Journal
Isaac Melo MD,1 Dolores Escobedo MSN,2 Karla Aguilar MD,3 Wendy Aguilar MD,3 Yazzmin Ballesteros MD,4 Carlos Durazo MD,3 Omar Guerrero MD5


Objetives: Cancer treatments have managed to improve survival but leaving limitations on quality of life with consequences for sexuality. There is currently no adequate treatment for sexual dysfunction secondary to cancer treatment. Cancer centers offer multidisciplinary treatments with poor therapeutic response. It is necessary to find new and better ways to deal with this problem. In the last 20 years Platelet Rich Plasma (PRP) has been used in different medical areas with reparative and functional effects.
Methods: Original, Quasi-experimental pilot survey. 21 volunteer patients were treated in four sessions of vulvar and vaginal PRP application.
Results: Improvement in the Female Sexual Health Index (FSFI), Vaginal Health Index (VHI), and ability of introitus distention with statistical verification was archived, without improvement in vaginal length. Increase in FSFI from 12.8 to 30.1, ISV from 16 to 20.
Conclusion: Platelet Rich Plasma is a magnificent choice in the treatment of Sexual Dysfunction Secondary to Cancer. Its effect on tissue


dyspareunia, platelet rich plasma, female sexual dysfunction, female sexual arousal disorder, female orgasmic disorder, female cancer treatment, cancer survivor